nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadodiamide—Anaphylactic shock—Vemurafenib—skin cancer	0.00312	0.00312	CcSEcCtD
Gadodiamide—Infection—Vemurafenib—skin cancer	0.0031	0.0031	CcSEcCtD
Gadodiamide—Cardiac failure—Fluorouracil—skin cancer	0.00306	0.00306	CcSEcCtD
Gadodiamide—Nervous system disorder—Vemurafenib—skin cancer	0.00306	0.00306	CcSEcCtD
Gadodiamide—Ataxia—Temozolomide—skin cancer	0.00305	0.00305	CcSEcCtD
Gadodiamide—Ill-defined disorder—Imiquimod—skin cancer	0.00302	0.00302	CcSEcCtD
Gadodiamide—Nausea—Vismodegib—skin cancer	0.003	0.003	CcSEcCtD
Gadodiamide—Injection site reaction—Docetaxel—skin cancer	0.00295	0.00295	CcSEcCtD
Gadodiamide—Malaise—Imiquimod—skin cancer	0.00294	0.00294	CcSEcCtD
Gadodiamide—Syncope—Imiquimod—skin cancer	0.00292	0.00292	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Bleomycin—skin cancer	0.00292	0.00292	CcSEcCtD
Gadodiamide—Hypotension—Vemurafenib—skin cancer	0.00291	0.00291	CcSEcCtD
Gadodiamide—Myocardial infarction—Bleomycin—skin cancer	0.0029	0.0029	CcSEcCtD
Gadodiamide—Loss of consciousness—Imiquimod—skin cancer	0.00286	0.00286	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00284	0.00284	CcSEcCtD
Gadodiamide—Convulsion—Imiquimod—skin cancer	0.00282	0.00282	CcSEcCtD
Gadodiamide—Ataxia—Fluorouracil—skin cancer	0.00281	0.00281	CcSEcCtD
Gadodiamide—Arthralgia—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Gadodiamide—Chest pain—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Gadodiamide—Myalgia—Imiquimod—skin cancer	0.00277	0.00277	CcSEcCtD
Gadodiamide—Anxiety—Imiquimod—skin cancer	0.00276	0.00276	CcSEcCtD
Gadodiamide—Discomfort—Imiquimod—skin cancer	0.00274	0.00274	CcSEcCtD
Gadodiamide—Sweating increased—Temozolomide—skin cancer	0.00273	0.00273	CcSEcCtD
Gadodiamide—Dry mouth—Imiquimod—skin cancer	0.00271	0.00271	CcSEcCtD
Gadodiamide—Fatigue—Vemurafenib—skin cancer	0.00269	0.00269	CcSEcCtD
Gadodiamide—Oedema—Imiquimod—skin cancer	0.00266	0.00266	CcSEcCtD
Gadodiamide—Lightheadedness—Docetaxel—skin cancer	0.00266	0.00266	CcSEcCtD
Gadodiamide—Infection—Imiquimod—skin cancer	0.00264	0.00264	CcSEcCtD
Gadodiamide—Shock—Imiquimod—skin cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Nervous system disorder—Imiquimod—skin cancer	0.00261	0.00261	CcSEcCtD
Gadodiamide—Tachycardia—Imiquimod—skin cancer	0.00259	0.00259	CcSEcCtD
Gadodiamide—Hyperhidrosis—Imiquimod—skin cancer	0.00257	0.00257	CcSEcCtD
Gadodiamide—Phlebitis—Docetaxel—skin cancer	0.0025	0.0025	CcSEcCtD
Gadodiamide—Flushing—Bleomycin—skin cancer	0.00247	0.00247	CcSEcCtD
Gadodiamide—Body temperature increased—Vemurafenib—skin cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Pharyngitis—Dactinomycin—skin cancer	0.00246	0.00246	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Temozolomide—skin cancer	0.00245	0.00245	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00242	0.00242	CcSEcCtD
Gadodiamide—Paraesthesia—Imiquimod—skin cancer	0.00239	0.00239	CcSEcCtD
Gadodiamide—Chills—Bleomycin—skin cancer	0.00238	0.00238	CcSEcCtD
Gadodiamide—Dyspnoea—Imiquimod—skin cancer	0.00237	0.00237	CcSEcCtD
Gadodiamide—Somnolence—Imiquimod—skin cancer	0.00236	0.00236	CcSEcCtD
Gadodiamide—Dyspepsia—Imiquimod—skin cancer	0.00234	0.00234	CcSEcCtD
Gadodiamide—Hot flush—Docetaxel—skin cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Flushing—Dactinomycin—skin cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Hypersensitivity—Vemurafenib—skin cancer	0.0023	0.0023	CcSEcCtD
Gadodiamide—Fatigue—Imiquimod—skin cancer	0.00229	0.00229	CcSEcCtD
Gadodiamide—Menopausal symptoms—Docetaxel—skin cancer	0.00228	0.00228	CcSEcCtD
Gadodiamide—Visual disturbance—Docetaxel—skin cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Pain—Imiquimod—skin cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Fluorouracil—skin cancer	0.00227	0.00227	CcSEcCtD
Gadodiamide—Renal impairment—Docetaxel—skin cancer	0.00226	0.00226	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Fluorouracil—skin cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Myocardial infarction—Fluorouracil—skin cancer	0.00225	0.00225	CcSEcCtD
Gadodiamide—Asthenia—Vemurafenib—skin cancer	0.00224	0.00224	CcSEcCtD
Gadodiamide—Hallucination—Temozolomide—skin cancer	0.00223	0.00223	CcSEcCtD
Gadodiamide—Pharyngitis—Temozolomide—skin cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Chills—Dactinomycin—skin cancer	0.00222	0.00222	CcSEcCtD
Gadodiamide—Urinary tract disorder—Temozolomide—skin cancer	0.00221	0.00221	CcSEcCtD
Gadodiamide—Cardiac failure—Docetaxel—skin cancer	0.00221	0.00221	CcSEcCtD
Gadodiamide—Pruritus—Vemurafenib—skin cancer	0.0022	0.0022	CcSEcCtD
Gadodiamide—Urethral disorder—Temozolomide—skin cancer	0.0022	0.0022	CcSEcCtD
Gadodiamide—Feeling abnormal—Imiquimod—skin cancer	0.00219	0.00219	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Imiquimod—skin cancer	0.00217	0.00217	CcSEcCtD
Gadodiamide—Hyponatraemia—Docetaxel—skin cancer	0.00216	0.00216	CcSEcCtD
Gadodiamide—Visual impairment—Temozolomide—skin cancer	0.00216	0.00216	CcSEcCtD
Gadodiamide—Ill-defined disorder—Bleomycin—skin cancer	0.00215	0.00215	CcSEcCtD
Gadodiamide—Diarrhoea—Vemurafenib—skin cancer	0.00213	0.00213	CcSEcCtD
Gadodiamide—Migraine—Docetaxel—skin cancer	0.00212	0.00212	CcSEcCtD
Gadodiamide—Urticaria—Imiquimod—skin cancer	0.00211	0.00211	CcSEcCtD
Gadodiamide—Abdominal pain—Imiquimod—skin cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Body temperature increased—Imiquimod—skin cancer	0.0021	0.0021	CcSEcCtD
Gadodiamide—Tinnitus—Temozolomide—skin cancer	0.00209	0.00209	CcSEcCtD
Gadodiamide—Malaise—Bleomycin—skin cancer	0.00209	0.00209	CcSEcCtD
Gadodiamide—Flushing—Temozolomide—skin cancer	0.00208	0.00208	CcSEcCtD
Gadodiamide—Rhinitis—Fluorouracil—skin cancer	0.00207	0.00207	CcSEcCtD
Gadodiamide—Dizziness—Vemurafenib—skin cancer	0.00206	0.00206	CcSEcCtD
Gadodiamide—Pharyngitis—Fluorouracil—skin cancer	0.00205	0.00205	CcSEcCtD
Gadodiamide—Ataxia—Docetaxel—skin cancer	0.00203	0.00203	CcSEcCtD
Gadodiamide—Chills—Temozolomide—skin cancer	0.00201	0.00201	CcSEcCtD
Gadodiamide—Ill-defined disorder—Dactinomycin—skin cancer	0.002	0.002	CcSEcCtD
Gadodiamide—Vomiting—Vemurafenib—skin cancer	0.00198	0.00198	CcSEcCtD
Gadodiamide—Myalgia—Bleomycin—skin cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Chest pain—Bleomycin—skin cancer	0.00197	0.00197	CcSEcCtD
Gadodiamide—Rash—Vemurafenib—skin cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Dermatitis—Vemurafenib—skin cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Hypersensitivity—Imiquimod—skin cancer	0.00196	0.00196	CcSEcCtD
Gadodiamide—Headache—Vemurafenib—skin cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Discomfort—Bleomycin—skin cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Malaise—Dactinomycin—skin cancer	0.00195	0.00195	CcSEcCtD
Gadodiamide—Dysgeusia—Temozolomide—skin cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Asthenia—Imiquimod—skin cancer	0.00191	0.00191	CcSEcCtD
Gadodiamide—Oedema—Bleomycin—skin cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Anaphylactic shock—Bleomycin—skin cancer	0.00189	0.00189	CcSEcCtD
Gadodiamide—Pruritus—Imiquimod—skin cancer	0.00188	0.00188	CcSEcCtD
Gadodiamide—Infection—Bleomycin—skin cancer	0.00188	0.00188	CcSEcCtD
Gadodiamide—Nausea—Vemurafenib—skin cancer	0.00185	0.00185	CcSEcCtD
Gadodiamide—Arrhythmia—Fluorouracil—skin cancer	0.00184	0.00184	CcSEcCtD
Gadodiamide—Myalgia—Dactinomycin—skin cancer	0.00184	0.00184	CcSEcCtD
Gadodiamide—Bronchospasm—Docetaxel—skin cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Tremor—Temozolomide—skin cancer	0.00183	0.00183	CcSEcCtD
Gadodiamide—Diarrhoea—Imiquimod—skin cancer	0.00182	0.00182	CcSEcCtD
Gadodiamide—Discomfort—Dactinomycin—skin cancer	0.00181	0.00181	CcSEcCtD
Gadodiamide—Ill-defined disorder—Temozolomide—skin cancer	0.00181	0.00181	CcSEcCtD
Gadodiamide—Hypotension—Bleomycin—skin cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Oedema—Dactinomycin—skin cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Malaise—Temozolomide—skin cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Dizziness—Imiquimod—skin cancer	0.00176	0.00176	CcSEcCtD
Gadodiamide—Infection—Dactinomycin—skin cancer	0.00175	0.00175	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.00172	0.00172	CcSEcCtD
Gadodiamide—Paraesthesia—Bleomycin—skin cancer	0.00169	0.00169	CcSEcCtD
Gadodiamide—Convulsion—Temozolomide—skin cancer	0.00169	0.00169	CcSEcCtD
Gadodiamide—Vomiting—Imiquimod—skin cancer	0.00169	0.00169	CcSEcCtD
Gadodiamide—Dyspnoea—Bleomycin—skin cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Rash—Imiquimod—skin cancer	0.00168	0.00168	CcSEcCtD
Gadodiamide—Dermatitis—Imiquimod—skin cancer	0.00167	0.00167	CcSEcCtD
Gadodiamide—Headache—Imiquimod—skin cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Arthralgia—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Myalgia—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Anxiety—Temozolomide—skin cancer	0.00166	0.00166	CcSEcCtD
Gadodiamide—Discomfort—Temozolomide—skin cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Acute coronary syndrome—Docetaxel—skin cancer	0.00164	0.00164	CcSEcCtD
Gadodiamide—Renal failure—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Neuropathy peripheral—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Myocardial infarction—Docetaxel—skin cancer	0.00163	0.00163	CcSEcCtD
Gadodiamide—Dry mouth—Temozolomide—skin cancer	0.00162	0.00162	CcSEcCtD
Gadodiamide—Pain—Bleomycin—skin cancer	0.00161	0.00161	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.0016	0.0016	CcSEcCtD
Gadodiamide—Anaphylactic shock—Temozolomide—skin cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Oedema—Temozolomide—skin cancer	0.00159	0.00159	CcSEcCtD
Gadodiamide—Infection—Temozolomide—skin cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Nausea—Imiquimod—skin cancer	0.00158	0.00158	CcSEcCtD
Gadodiamide—Nervous system disorder—Temozolomide—skin cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Convulsion—Fluorouracil—skin cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Feeling abnormal—Bleomycin—skin cancer	0.00156	0.00156	CcSEcCtD
Gadodiamide—Hyperhidrosis—Temozolomide—skin cancer	0.00154	0.00154	CcSEcCtD
Gadodiamide—Myalgia—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Chest pain—Fluorouracil—skin cancer	0.00153	0.00153	CcSEcCtD
Gadodiamide—Fatigue—Dactinomycin—skin cancer	0.00152	0.00152	CcSEcCtD
Gadodiamide—Discomfort—Fluorouracil—skin cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Pain—Dactinomycin—skin cancer	0.00151	0.00151	CcSEcCtD
Gadodiamide—Urticaria—Bleomycin—skin cancer	0.0015	0.0015	CcSEcCtD
Gadodiamide—Rhinitis—Docetaxel—skin cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Body temperature increased—Bleomycin—skin cancer	0.00149	0.00149	CcSEcCtD
Gadodiamide—Pharyngitis—Docetaxel—skin cancer	0.00148	0.00148	CcSEcCtD
Gadodiamide—Urinary tract disorder—Docetaxel—skin cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Anaphylactic shock—Fluorouracil—skin cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Oedema—Fluorouracil—skin cancer	0.00147	0.00147	CcSEcCtD
Gadodiamide—Urethral disorder—Docetaxel—skin cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Infection—Fluorouracil—skin cancer	0.00146	0.00146	CcSEcCtD
Gadodiamide—Feeling abnormal—Dactinomycin—skin cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00145	0.00145	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Dactinomycin—skin cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Nervous system disorder—Fluorouracil—skin cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Visual impairment—Docetaxel—skin cancer	0.00144	0.00144	CcSEcCtD
Gadodiamide—Tachycardia—Fluorouracil—skin cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Paraesthesia—Temozolomide—skin cancer	0.00143	0.00143	CcSEcCtD
Gadodiamide—Dyspnoea—Temozolomide—skin cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Somnolence—Temozolomide—skin cancer	0.00142	0.00142	CcSEcCtD
Gadodiamide—Dyspepsia—Temozolomide—skin cancer	0.0014	0.0014	CcSEcCtD
Gadodiamide—Abdominal pain—Dactinomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Body temperature increased—Dactinomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Hypersensitivity—Bleomycin—skin cancer	0.00139	0.00139	CcSEcCtD
Gadodiamide—Flushing—Docetaxel—skin cancer	0.00138	0.00138	CcSEcCtD
Gadodiamide—Fatigue—Temozolomide—skin cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Hypotension—Fluorouracil—skin cancer	0.00137	0.00137	CcSEcCtD
Gadodiamide—Pain—Temozolomide—skin cancer	0.00136	0.00136	CcSEcCtD
Gadodiamide—Asthenia—Bleomycin—skin cancer	0.00135	0.00135	CcSEcCtD
Gadodiamide—Chills—Docetaxel—skin cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Pruritus—Bleomycin—skin cancer	0.00134	0.00134	CcSEcCtD
Gadodiamide—Arrhythmia—Docetaxel—skin cancer	0.00133	0.00133	CcSEcCtD
Gadodiamide—Paraesthesia—Fluorouracil—skin cancer	0.00132	0.00132	CcSEcCtD
Gadodiamide—Feeling abnormal—Temozolomide—skin cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Dyspnoea—Fluorouracil—skin cancer	0.00131	0.00131	CcSEcCtD
Gadodiamide—Somnolence—Fluorouracil—skin cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Temozolomide—skin cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Hypersensitivity—Dactinomycin—skin cancer	0.0013	0.0013	CcSEcCtD
Gadodiamide—Dyspepsia—Fluorouracil—skin cancer	0.00129	0.00129	CcSEcCtD
Gadodiamide—Dysgeusia—Docetaxel—skin cancer	0.00127	0.00127	CcSEcCtD
Gadodiamide—Urticaria—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Asthenia—Dactinomycin—skin cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Body temperature increased—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Abdominal pain—Temozolomide—skin cancer	0.00126	0.00126	CcSEcCtD
Gadodiamide—Pain—Fluorouracil—skin cancer	0.00125	0.00125	CcSEcCtD
Gadodiamide—Feeling abnormal—Fluorouracil—skin cancer	0.00121	0.00121	CcSEcCtD
Gadodiamide—Diarrhoea—Dactinomycin—skin cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Vomiting—Bleomycin—skin cancer	0.0012	0.0012	CcSEcCtD
Gadodiamide—Rash—Bleomycin—skin cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Dermatitis—Bleomycin—skin cancer	0.00119	0.00119	CcSEcCtD
Gadodiamide—Hypersensitivity—Temozolomide—skin cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Urticaria—Fluorouracil—skin cancer	0.00117	0.00117	CcSEcCtD
Gadodiamide—Syncope—Docetaxel—skin cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Body temperature increased—Fluorouracil—skin cancer	0.00116	0.00116	CcSEcCtD
Gadodiamide—Asthenia—Temozolomide—skin cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Loss of consciousness—Docetaxel—skin cancer	0.00114	0.00114	CcSEcCtD
Gadodiamide—Pruritus—Temozolomide—skin cancer	0.00113	0.00113	CcSEcCtD
Gadodiamide—Convulsion—Docetaxel—skin cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Nausea—Bleomycin—skin cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Vomiting—Dactinomycin—skin cancer	0.00112	0.00112	CcSEcCtD
Gadodiamide—Rash—Dactinomycin—skin cancer	0.00111	0.00111	CcSEcCtD
Gadodiamide—Chest pain—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Myalgia—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Arthralgia—Docetaxel—skin cancer	0.0011	0.0011	CcSEcCtD
Gadodiamide—Diarrhoea—Temozolomide—skin cancer	0.00109	0.00109	CcSEcCtD
Gadodiamide—Hypersensitivity—Fluorouracil—skin cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Dry mouth—Docetaxel—skin cancer	0.00108	0.00108	CcSEcCtD
Gadodiamide—Oedema—Docetaxel—skin cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Anaphylactic shock—Docetaxel—skin cancer	0.00106	0.00106	CcSEcCtD
Gadodiamide—Dizziness—Temozolomide—skin cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Infection—Docetaxel—skin cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Nausea—Dactinomycin—skin cancer	0.00105	0.00105	CcSEcCtD
Gadodiamide—Shock—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Nervous system disorder—Docetaxel—skin cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Pruritus—Fluorouracil—skin cancer	0.00104	0.00104	CcSEcCtD
Gadodiamide—Tachycardia—Docetaxel—skin cancer	0.00103	0.00103	CcSEcCtD
Gadodiamide—Vomiting—Temozolomide—skin cancer	0.00101	0.00101	CcSEcCtD
Gadodiamide—Rash—Temozolomide—skin cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Diarrhoea—Fluorouracil—skin cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Dermatitis—Temozolomide—skin cancer	0.001	0.001	CcSEcCtD
Gadodiamide—Headache—Temozolomide—skin cancer	0.000997	0.000997	CcSEcCtD
Gadodiamide—Hypotension—Docetaxel—skin cancer	0.000989	0.000989	CcSEcCtD
Gadodiamide—Dizziness—Fluorouracil—skin cancer	0.00097	0.00097	CcSEcCtD
Gadodiamide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000965	0.000965	CcSEcCtD
Gadodiamide—Paraesthesia—Docetaxel—skin cancer	0.000951	0.000951	CcSEcCtD
Gadodiamide—Nausea—Temozolomide—skin cancer	0.000946	0.000946	CcSEcCtD
Gadodiamide—Dyspnoea—Docetaxel—skin cancer	0.000944	0.000944	CcSEcCtD
Gadodiamide—Somnolence—Docetaxel—skin cancer	0.000941	0.000941	CcSEcCtD
Gadodiamide—Vomiting—Fluorouracil—skin cancer	0.000933	0.000933	CcSEcCtD
Gadodiamide—Dyspepsia—Docetaxel—skin cancer	0.000932	0.000932	CcSEcCtD
Gadodiamide—Rash—Fluorouracil—skin cancer	0.000925	0.000925	CcSEcCtD
Gadodiamide—Dermatitis—Fluorouracil—skin cancer	0.000924	0.000924	CcSEcCtD
Gadodiamide—Headache—Fluorouracil—skin cancer	0.000919	0.000919	CcSEcCtD
Gadodiamide—Fatigue—Docetaxel—skin cancer	0.000913	0.000913	CcSEcCtD
Gadodiamide—Pain—Docetaxel—skin cancer	0.000905	0.000905	CcSEcCtD
Gadodiamide—Feeling abnormal—Docetaxel—skin cancer	0.000873	0.000873	CcSEcCtD
Gadodiamide—Nausea—Fluorouracil—skin cancer	0.000871	0.000871	CcSEcCtD
Gadodiamide—Gastrointestinal pain—Docetaxel—skin cancer	0.000866	0.000866	CcSEcCtD
Gadodiamide—Abdominal pain—Docetaxel—skin cancer	0.000837	0.000837	CcSEcCtD
Gadodiamide—Body temperature increased—Docetaxel—skin cancer	0.000837	0.000837	CcSEcCtD
Gadodiamide—Hypersensitivity—Docetaxel—skin cancer	0.00078	0.00078	CcSEcCtD
Gadodiamide—Asthenia—Docetaxel—skin cancer	0.00076	0.00076	CcSEcCtD
Gadodiamide—Pruritus—Docetaxel—skin cancer	0.000749	0.000749	CcSEcCtD
Gadodiamide—Diarrhoea—Docetaxel—skin cancer	0.000724	0.000724	CcSEcCtD
Gadodiamide—Dizziness—Docetaxel—skin cancer	0.0007	0.0007	CcSEcCtD
Gadodiamide—Vomiting—Docetaxel—skin cancer	0.000673	0.000673	CcSEcCtD
Gadodiamide—Rash—Docetaxel—skin cancer	0.000668	0.000668	CcSEcCtD
Gadodiamide—Dermatitis—Docetaxel—skin cancer	0.000667	0.000667	CcSEcCtD
Gadodiamide—Headache—Docetaxel—skin cancer	0.000663	0.000663	CcSEcCtD
Gadodiamide—Nausea—Docetaxel—skin cancer	0.000629	0.000629	CcSEcCtD
